Sandbox:Sahar: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 24: Line 24:
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG view}}
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG view}}
|-
|-
! style="padding: 5px 5px; background: #DCDCDC; " align="left"| Ventricular tachycardia
! style="padding: 5px 5px; background: #DCDCDC; " align="left"| Ventricular tachycardia<ref name="AjijolaTung2014">{{cite journal|last1=Ajijola|first1=Olujimi A.|last2=Tung|first2=Roderick|last3=Shivkumar|first3=Kalyanam|title=Ventricular tachycardia in ischemic heart disease substrates|journal=Indian Heart Journal|volume=66|year=2014|pages=S24–S34|issn=00194832|doi=10.1016/j.ihj.2013.12.039}}</ref><ref name="Meja LopezMalhotra2019">{{cite journal|last1=Meja Lopez|first1=Eliany|last2=Malhotra|first2=Rohit|title=Ventricular Tachycardia in Structural Heart Disease|journal=Journal of Innovations in Cardiac Rhythm Management|volume=10|issue=8|year=2019|pages=3762–3773|issn=21563977|doi=10.19102/icrm.2019.100801}}</ref><ref name="CoughtrieBehr2017">{{cite journal|last1=Coughtrie|first1=Abigail L|last2=Behr|first2=Elijah R|last3=Layton|first3=Deborah|last4=Marshall|first4=Vanessa|last5=Camm|first5=A John|last6=Shakir|first6=Saad A W|title=Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort|journal=BMJ Open|volume=7|issue=10|year=2017|pages=e016627|issn=2044-6055|doi=10.1136/bmjopen-2017-016627}}</ref><ref name="El-Sherif2001">{{cite journal|last1=El-Sherif|first1=Nabil|title=Mechanism of Ventricular Arrhythmias in the Long QT Syndrome: On Hermeneutics|journal=Journal of Cardiovascular Electrophysiology|volume=12|issue=8|year=2001|pages=973–976|issn=1045-3873|doi=10.1046/j.1540-8167.2001.00973.x}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |  
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |  
*
*[[Ischemic heart disease]]
*Illicit drug use such as [[cocaine]] and [[methamphetamine]]
*[[Structural heart diseases]]
*[[Electrolyte disturbances]]
*[[Congestive heart failure]]
*[[Myocarditis]]
*[[Obstructive sleep apnea]]
*[[Pulmonary artery catheter]]
*[[Long QT syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*
*
Line 40: Line 48:
*
*
|-
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="left" | Asystole
! style="padding: 5px 5px; background: #DCDCDC;" align="left" | Asystole<ref name=ACLS_2003_H_T>''ACLS: Principles and Practice''. p. 71-87. Dallas: American Heart Association, 2003. ISBN 0-87493-341-2.</ref><ref name=ACLS_2003_EP_HT>''ACLS for Experienced Providers''. p. 3-5. Dallas: American Heart Association, 2003. ISBN 0-87493-424-9.</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*
*[[Hypovolemia]]
*[[Hypoxia (medical)|Hypoxia]]
*[[Acidosis]]
*[[Hypothermia|Hypothermia]]
*[[Hyperkalemia|Hyperkalemia]] or [[Hypokalemia|Hypokalemia]]
*[[Hypoglycemia|Hypoglycemia]]
*[[Cardiac tamponade|Cardiac Tamponade]]
*[[Tension pneumothorax|Tension pneumothorax]]
*[[Thrombosis|Thrombosis]]
*[[Myocardial infarction]]
*[[Thrombosis|Thrombosis]]
*[[Pulmonary embolism]]
*[[Cardiogenic shock]]
*Degeneration of the [[sinoatrial]] or [[atrioventricular]] nodes
*[[Ischemic stroke]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*
* There is no electrical activity in the asystole
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*
[[Image:Lead II rhythm generated asystole.JPG|center|300px]]
|-
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="left" | Pulseless electrical activity<ref name=ACLS_2003_H_T>''ACLS: Principles and Practice''. p. 71-87. Dallas: American Heart Association, 2003. ISBN 0-87493-341-2.</ref><ref name=ACLS_2003_EP_HT>''ACLS for Experienced Providers''. p. 3-5. Dallas: American Heart Association, 2003. ISBN 0-87493-424-9.</ref><ref name="ECC_2005_7.2">"2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care - Part 7.2: Management of Cardiac Arrest." ''Circulation'' 2005; '''112''': IV-58 - IV-66.</ref><ref>Foster B, Twelve Lead Electrocardiography, 2nd edition, 2007</ref>
! style="padding: 5px 5px; background: #DCDCDC;" align="left" | Pulseless electrical activity<ref name="ECC_2005_7.2">"2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care - Part 7.2: Management of Cardiac Arrest." ''Circulation'' 2005; '''112''': IV-58 - IV-66.</ref><ref>Foster B, Twelve Lead Electrocardiography, 2nd edition, 2007</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Hypovolemia
*Hypovolemia

Revision as of 20:04, 28 January 2020

Images

Contrast enhanced CT: Aortic intramural hematoma, Courtesy of radiopaedia


Contrast enhanced CT: Aortic intramural hematoma, Courtesy of radiopaedia


Contrast enhanced CT: Aortic intramural hematoma, Courtesy of radiopaedia


Contrast enhanced CT: Aortic intramural hematoma, Courtesy of radiopaedia


Contrast enhanced CT: Aortic intramural hematoma, Courtesy of radiopaedia


Contrast enhanced CT: Aortic intramural hematoma, Courtesy of radiopaedia



Disease Name Causes ECG Characteristics ECG view
Ventricular tachycardia[1][2][3][4]
Ventricular fibrillation
Asystole[5][6]
  • There is no electrical activity in the asystole
Pulseless electrical activity[7][8]
  • Hypovolemia
  • Hypoxia
  • Hydrogen ions (Acidosis)
  • Hypothermia
  • Hyperkalemia or Hypokalemia
  • Hypoglycemia
  • Tablets or Toxins (Drug overdose) such as beta blockers, tricyclic antidepressants, or calcium channel blockers
  • Tamponade
  • Tension pneumothorax
  • Thrombosis (Myocardial infarction)
  • Thrombosis (Pulmonary embolism)
  • Trauma (Hypovolemia from blood loss)
  • Several ppattern are possible including:
    • Normal sinus rhythm
    • Sinus tachycardia, with discernible P waves and QRS complexes
    • Bradycardia, with or without P waves
Pulmonary embolism
  1. ↑ Ajijola, Olujimi A.; Tung, Roderick; Shivkumar, Kalyanam (2014). "Ventricular tachycardia in ischemic heart disease substrates". Indian Heart Journal. 66: S24–S34. doi:10.1016/j.ihj.2013.12.039. ISSN 0019-4832.
  2. ↑ Meja Lopez, Eliany; Malhotra, Rohit (2019). "Ventricular Tachycardia in Structural Heart Disease". Journal of Innovations in Cardiac Rhythm Management. 10 (8): 3762–3773. doi:10.19102/icrm.2019.100801. ISSN 2156-3977.
  3. ↑ Coughtrie, Abigail L; Behr, Elijah R; Layton, Deborah; Marshall, Vanessa; Camm, A John; Shakir, Saad A W (2017). "Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort". BMJ Open. 7 (10): e016627. doi:10.1136/bmjopen-2017-016627. ISSN 2044-6055.
  4. ↑ El-Sherif, Nabil (2001). "Mechanism of Ventricular Arrhythmias in the Long QT Syndrome: On Hermeneutics". Journal of Cardiovascular Electrophysiology. 12 (8): 973–976. doi:10.1046/j.1540-8167.2001.00973.x. ISSN 1045-3873.
  5. ↑ ACLS: Principles and Practice. p. 71-87. Dallas: American Heart Association, 2003. ISBN 0-87493-341-2.
  6. ↑ ACLS for Experienced Providers. p. 3-5. Dallas: American Heart Association, 2003. ISBN 0-87493-424-9.
  7. ↑ "2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care - Part 7.2: Management of Cardiac Arrest." Circulation 2005; 112: IV-58 - IV-66.
  8. ↑ Foster B, Twelve Lead Electrocardiography, 2nd edition, 2007


Disease Name Age of Onset Gender Preponderance Signs/Symptoms Imaging Feature(s) Macroscopic Feature(s) Microscopic Feature(s) Laboratory Findings(s) Other Feature(s) ECG view
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:Sahar&oldid=1596670"